Low serum uric acid levels are associated with the nonmotor symptoms and brain gray matter volume in Parkinson’s disease

[1] Schapira AHV(2017)Non-motor features of Parkinson disease Nat Rev Neurosci 18 435-450

[2] Chaudhuri KR(2019)Incidence and prevalence of Parkinson’s disease in the Italian region of Umbria: a population-based study using healthcare administrative databases Neurol Sci 40 1709-1712

[3] Jenner P(2013)EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson’s disease Eur J Neurol 20 16-34

[4] Eusebi P(2018)Serum uric acid level and its association with motor subtypes and non-motor symptoms in early Parkinson’s disease: PALS study Parkinsonism Relat Disord 55 50-54

[5] Franchini D(1994)Alterations in glutathione levels in Parkinson’s disease and other neurodegenerative disorders affecting basal ganglia Ann Neurol 36 348-355

[6] De Giorgi M(2003)Oxidative stress in Parkinson’s disease Ann Neurol 53 S26-36

[7] Abraha I(2019)Understanding multifactorial architecture of Parkinson’s disease: pathophysiology to management Neurol Sci 40 13-23

[8] Montedori A(2005)Uric acid and oxidative stress Curr Pharm Des 11 4145-4151

[9] Casucci P(2008)Altered uric acid levels and disease states J Pharmacol Exp Ther 324 1-7

[10] Calabresi P(2000)Voxel-based morphometry—the methods Neuroimage 11 805-821

[1] Schapira AHV(2017)Non-motor features of Parkinson disease Nat Rev Neurosci 18 435-450

[2] Chaudhuri KR(2019)Incidence and prevalence of Parkinson’s disease in the Italian region of Umbria: a population-based study using healthcare administrative databases Neurol Sci 40 1709-1712

[3] Jenner P(2013)EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson’s disease Eur J Neurol 20 16-34

[4] Eusebi P(2018)Serum uric acid level and its association with motor subtypes and non-motor symptoms in early Parkinson’s disease: PALS study Parkinsonism Relat Disord 55 50-54

[5] Franchini D(1994)Alterations in glutathione levels in Parkinson’s disease and other neurodegenerative disorders affecting basal ganglia Ann Neurol 36 348-355

[6] De Giorgi M(2003)Oxidative stress in Parkinson’s disease Ann Neurol 53 S26-36

[7] Abraha I(2019)Understanding multifactorial architecture of Parkinson’s disease: pathophysiology to management Neurol Sci 40 13-23

[8] Montedori A(2005)Uric acid and oxidative stress Curr Pharm Des 11 4145-4151

[9] Casucci P(2008)Altered uric acid levels and disease states J Pharmacol Exp Ther 324 1-7

[10] Calabresi P(2000)Voxel-based morphometry—the methods Neuroimage 11 805-821